Sign Up to like & get
recommendations!
0
Published in 2017 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.13184
Abstract: Aims A recombinant human serum albumin‐interferon alpha2a fusion protein (rHSA/IFN&agr;2a) is expected to extend the half‐life of IFN&agr;2a. This study aims to evaluate the tolerability, safety and efficacy of rHSA/IFN&agr;2a. Methods This is an open,…
read more here.
Keywords:
rhsa ifn;
treatment;
ifn;
ifn agr ... See more keywords